Skip to main content

Currently Skimming:

5 Research Integrity and the Responsible Conduct of Research
Pages 35-42

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 35...
... Resnick is often called in to provide advice when ethical issues arise in research. Most of the issues that he sees involve authorship, with some disputes arising about data management or intellectual property.
From page 36...
... MD. Researchers also vary with respect to their knowledge and training on the responsible conduct of research and specific issues such as data management, authorship, publication, and research integrity.
From page 37...
... A written collaboration agreement does not supersede other sorts of agreements that exist in research, such as material transfer agreements, data use agreements, confidentiality agreements, cooperative research and development agreements, and memoranda of understanding. These are all important but none of them addresses some of the key issues discussed above.
From page 38...
... HIV Vaccine Trials Unit, University of Maryland; and Aliyu Gambo Gumel, Fogarty International Research Fellow, discussed their research project on Recruiting Acute Cases of HIV in Nigeria, the REACH Study. The sponsor was the Centers for Disease Control, and the research was undertaken collaboratively by the University of Maryland and the Nigerian Federal Ministry of Health.
From page 39...
... Dr. Aliyu discussed the ways in which the project increased the capacity for the Nigerian partners to ensure data integrity, by developing effective methods for data collection, storage, transfer and validation.
From page 40...
... government agencies undertaken abroad will generally follow U.S. ethical conduct procedures, such as the Common Rule for human subjects protection, research collaboration is much easier when partner countries develop their own frameworks for institutional review boards, animal subjects protection, and so forth.
From page 41...
... This is a non-exhaustive list, and is not intended to represent consensus views of the workshop or the breakout session: · Possible Issues for Industry. Industry-supported research is mov ing offshore, particularly clinical trials in the pharmaceutical indus try.
From page 42...
... The government might clarify clinical trial responsibilities and accountability. The RCR training plan and mandates could be put on the front page of the grant along with human subjects, etc.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.